COPD?

Rethink your treatment options.

Chronic obstructive pulmonary disease (COPD) is a chronic disease usually caused by exposure to noxious particles or gases like cigarette smoke. Symptoms like coughing, shortness of breath, and wheezing make it difficult to keep up with normal activities, but we’re working on new options. Learn about the cutting-edge study treatments being investigated near you.

1/5

Americans age 45 years and older has COPD. ¹

37%

Women are 37% more likely to have COPD than men. ²

70%

of people with COPD say it limits physical activity. ³

COPD Clinical Trials

Learn about the newest COPD study treatments now being investigated, including cutting-edge study options available to clinical trial participants.

TrialSpark is now recruiting for a trial that tests the effectiveness of a cystic fibrosis drug on COPD symptoms.

Learn More

Clinicaltrials.gov

Improving Cardiovascular Health in Patients With Chronic Obstructive...

Researchers have found a link between chronic obstructive pulmonary disease (COPD) and heart disease; however, a link is all they have found. Cardiovascular health in COPD is controlled by different mechanisms...

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

Virginia Commonwealth University

Clinicaltrials.gov

Dietary Intervention Increasing Omega-3 Intake

This Dietary Intervention is being done to evaluate the feasibility of a food voucher program and dietary counseling to increase consumption of healthy fatty acids (omega-3) in individuals with Chronic...

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

Johns Hopkins University

Clinicaltrials.gov

Fish Oil and HMB Supplementation in COPD

In the present study, the role of chronic (10 weeks) intake of low dose (2g/day) of EPA+DHA in whole body protein metabolism, and functional performance and systemic inflammation will be examined, and whether...

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

Texas A&M University

Clinicaltrials.gov

Gala Early Feasibility Study of RheOx

Feasibility trial (FIH) to assess the safety and clinical utility of RheOx on patients with chronic bronchitis in the United States.

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

Gala Therapeutics, Inc.

Clinicaltrials.gov

CREATION Health Readmission Risk Assessment Tool

This study occurs in two phases. Phase 1 involves initial item development and measurement validation of a new tool for identifying hospitalized patients at high risk for preventable readmission. Primary tasks...

Trial Type

Observational

Sponsorship

Florida Hospital

Clinicaltrials.gov

Nebulizer Versus Dry Powdered Inhalers for COPD

This will be a non-blinded feasibility (pilot) study comparing triple therapy nebulizer vs dry powdered inhalers (DPI) for care transitions in COPD exacerbation patients. We hypothesize that patients treated...

Trial Type

Interventional

Trial Phase

Phase 4

Sponsorship

Wake Forest University Health Sciences

Clinicaltrials.gov

Randomized Evaluation of Default Access to Palliative Services

This is a large pragmatic, randomized controlled trial to test the real-world effectiveness of inpatient palliative care consultative services in improving a number of patient- and family-centered processes...

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

National Institute on Aging (NIA)

Clinicaltrials.gov

Active for Life: Chronic Obstructive Pulmonary Disease

This study examines the effects of an exercise and behavioral program, called Active-Life, to promote physical activity in people with chronic obstructive pulmonary disease. A sedentary lifestyle is very...

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

University of Michigan

Clinicaltrials.gov

An Evaluation of Post Discharge Utilization Among Patients With an...

Patients who are hospitalized at select Carolinas Healthcare System (CHS) sites with Chronic Obstructive Pulmonary Disorder (COPD) acute exacerbation symptoms will be treated per the CHS COPD Clinical Pathway....

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

Atrium Health

Clinicaltrials.gov

Imaging of Apoptosis in Chronic Obstructive Pulmonary Disease (COPD)

This will be a prospective study examining the use of 99mTc-Annexin V-128 (AxV-128/Tc) single-photon emission computed tomography (SPECT)/computerized tomography (CT) technology in the imaging and functional...

Trial Type

Interventional

Trial Phase

Phase 2

Sponsorship

National Heart, Lung, and Blood Institute (NHLBI)

Clinicaltrials.gov

HFNC Effect on BCSS in Patients With COPD

The primary objective of this study is to look for a correlation between the use of HFNC in the outpatient setting in patients with previous COPD exacerbation and the change in their BCSS score. The hypothesis...

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

Fisher and Paykel Healthcare

Clinicaltrials.gov

Integrative-omics of the Disordered COPD Small Airway Epithelium

We aim to use an integrated network systems approach to analyze certain existing small airway epithelium (SAE) omic data sets at the genetic, epigenetic (methylation), gene expression, microRNA and metabolomic...

Trial Type

Observational

Sponsorship

Weill Medical College of Cornell University

Clinicaltrials.gov

Tezepelumab COPD Exacerbation Study

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2a Study to Explore the Efficacy and Safety of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive...

Trial Type

Interventional

Trial Phase

Phase 2

Sponsorship

Amgen

Clinicaltrials.gov

Study of Humidified Air to Improve Mucociliary Clearance (MCC) in COPD

This purpose of this study is to determine whether nasal delivery of heated and humidified air for a period of 4 hours will improve the clearance of mucus from the lungs of patients with chronic obstructive...

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

Fisher and Paykel Healthcare

Clinicaltrials.gov

At Home Spirometry and Video Module Education for COPD Patients

The central hypothesis is that patients hospitalized for COPD who subsequently complete the at-home BREATHES Program with V-TTG skill training and SpiroPD adherence support will retain increased medication...

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

National Heart, Lung, and Blood Institute (NHLBI)

Clinicaltrials.gov

Hyper Polarized Xenon-129 MRI vs Xenon-133 Scintigraphy

Hyper polarized Xenon-129 MRI will be directly compared to a radioactive Xe-133 scintigraphy to detect defects in lung ventilation from airflow limitation. This study is conducted as a pilot study with...

Trial Type

Interventional

Trial Phase

Phase 1/Phase 2

Sponsorship

University of Virginia

Clinicaltrials.gov

Feasibility of SpiroPD

The investigators' central hypotheses predict that the handheld spirometry device will be feasible for inpatient and at-home use, and is equally efficacious at determining lung function when compared to...

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

University of Chicago

Clinicaltrials.gov

Imaging of Peri-operative (periOP) Lung Injury

The aim of study is to determine if 99mTc Annexin V-128 (AxV- 128/Tc) single photon emission computed tomography (SPECT)-computed tomography (CT) can detect perioperative lung injury. The investigators will...

Trial Type

Interventional

Trial Phase

Phase 2

Sponsorship

National Heart, Lung, and Blood Institute (NHLBI)

Clinicaltrials.gov

Meditative Movement for COPD Symptoms in Non-Smoking Flight Attendants

This study will explore the a Qigong based exercise intervention, here referred to as Meditative Movement (MM), to ameliorate the symptoms associated with chronic obstructive pulmonary disease (COPD) and its...

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

Norris Cotton Cancer Center

Clinicaltrials.gov

Pivotal Study to Assess the Efficacy, Safety and Tolerability of...

Primary Objective: To evaluate the efficacy of dupilumab administered every 2 weeks in patients with moderate-or severe Chronic Obstructive Pulmonary Disease (COPD) as measured by - Annualized rate of acute...

Trial Type

Interventional

Trial Phase

Phase 3

Sponsorship

Regeneron Pharmaceuticals

Clinicaltrials.gov

Long-term Observational Study of the Safety of Roflumilast

This is a retrospective cohort study comparing COPD patients aged 40 years and older with new exposure to roflumilast with up to 5 unexposed (ie, not roflumilast-exposed) COPD controls matched by propensity...

Trial Type

Observational

Sponsorship

AstraZeneca

Clinicaltrials.gov

A Study for the Assessment of the Benefits of a Novel Mesh Nebulizer...

Jet nebulizers have been the standard delivery system for aerosolized medications commonly prescribed to Chronic Obstructive Pulmonary Disease (COPD) patients; however, these devices are inefficient and...

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

Philips Respironics

Clinicaltrials.gov

Study Investigating the Effect of 4 Doses of RPL554 Given in Addition...

The purpose of this study is to investigate the dose response of RPL554 in patients with moderate to severe CHRONIC OBSTRUCTIVE PULMONARY DISEASE that are still symptomatic despite treatment with a stable...

Trial Type

Interventional

Trial Phase

Phase 2

Sponsorship

LGC Limited

Clinicaltrials.gov

Increasing Physical Activity in COPD Through Rhythmically Enhanced...

The VA cares for nearly one million Veterans with COPD at a cost of more than $5.5 billion annually. COPD profoundly impairs quality of life as it limits ability to work, to maintain physical exertion and to...

Trial Type

Interventional

Trial Phase

Phase 3

Sponsorship

VA Office of Research and Development

Clinicaltrials.gov

The CAPTURE Study: Validating a Unique COPD Case Finding Tool in...

This is a qualitative research exploration engaging clinical staff at all levels from 10 Practice-Based Research Networks (PBRNs) serving US patient populations of differing gender, racial, ethnic, urban/rural...

Trial Type

Observational

Sponsorship

COPD Foundation

Clinicaltrials.gov

The CAPTURE Study: Validating a Unique COPD Case Finding Tool in...

A prospective multi-center study to define the sensitivity and specificity of CAPTURE for identifying previously undiagnosed patients with clinically significant COPD in a broad range of primary care settings.

Trial Type

Observational

Sponsorship

University of Kentucky

Clinicaltrials.gov

Smart Telehealth Exercise Intervention to Reduce COPD Readmissions

This is a prospective randomized controlled study to test the hypothesis that neuromuscular electrical stimulation (NMES) and remote pulmonary rehabilitation at home offered via a smart technology, called...

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

National Institutes of Health (NIH)

Clinicaltrials.gov

A Technology Assisted Care Transition Intervention for Veterans With...

Transition from hospital to home places patients in jeopardy of adverse events and increases their risk for rehospitalization. CHF is the most prevalent chronic condition among U.S. adults and COPD is the...

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

Northeastern University

Clinicaltrials.gov

The Effect of Chlorhexidine on the Oral and Lung Microbiota in...

Determine the effect of twice-daily chlorhexidine oral rinse on oral and lung microbiota biomass in subjects with chronic obstructive pulmonary disease (COPD) with chronic bronchitis. Our primary outcome will...

Trial Type

Interventional

Trial Phase

Phase 2

Sponsorship

Flight Attendant Medical Research Institute

Clinicaltrials.gov

Dose of Corticosteroids in COPD

COPD (chronic obstructive pulmonary disease) is a long-lasting lung disease usually caused by long-term smoking. COPD can get worse, making people sick enough to need hospitalization. Corticosteroids are very...

Trial Type

Interventional

Trial Phase

Phase 4

Sponsorship

Rutgers, The State University of New Jersey

Clinicaltrials.gov

Increasing Adherence to Pulmonary Rehabilitation After COPD Related...

This study will look at the effectiveness of a home-based Pulmonary Rehabilitation Program in patients who have recently been hospitalized for a COPD related cause.

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

National Heart, Lung, and Blood Institute (NHLBI)

Clinicaltrials.gov

Pulmonary Specialist-Health Coach Consult Model Pilot

The Pulmonary Specialist-Health Coach Consultation (PuSHCon) study examines the implementation of health coach-assisted consultations to improve access to specialist care and implementation of specialist...

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

National Heart, Lung, and Blood Institute (NHLBI)

Clinicaltrials.gov

RESP-FIT: Technology-Enhanced Self-Management in COPD

30 adults, aged 40 and older with mild to moderate COPD, will be recruited for this study. Participants must be willing to continually wear a FitBit activity monitor, have access to a smartphone or...

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

University of Florida

Clinicaltrials.gov

Evaluation of the Safety and Efficacy of TLD in Patients With COPD

The purpose of this study is to confirm the safety and efficacy of the Nuvaira Lung Denervation System (Nuvaira System) in the treatment of COPD.

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

Nuvaira, Inc.

Clinicaltrials.gov

Static Lung Hyperinflation and Sympathetic Nerve Activity-Associated...

The goal of this study is to evaluate the acute effects of a long-acting bronchodilator on pulmonary function, vascular function and muscle sympathetic nerve activity in individuals with COPD. Individuals will...

Trial Type

Interventional

Trial Phase

Phase 4

Sponsorship

Gary L. Pierce

Clinicaltrials.gov

The CAPTURE Study: Validating a Unique COPD Case Finding Tool in...

A prospective, multicenter study including a cross-section validation to define sensitivity and specificity of CAPTURE to identify previously undiagnosed patients with clinically significant Chronic...

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

COPD Foundation

Clinicaltrials.gov

Rehabilitation in Safety-net Settings for Patients With COPD

This study will examine COPD Wellness, a 10-week low-intensity pulmonary rehabilitation program consisting of group and home exercise, education, and social support can improve symptoms and increase physical...

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

Nina Ireland Program in Lung Health

Clinicaltrials.gov

A Comprehensive Disease Management Program to Improve Quality of Life...

Chronic Obstructive Pulmonary Disease (COPD), also known as emphysema, is the leading cause of hospitalization for older adults in the U.S., and a leading cause of death. Although there is no cure for COPD, a...

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

Patient-Centered Outcomes Research Institute

Clinicaltrials.gov

: Vascular Function in Health and Disease

Many control mechanisms exist which successfully match the supply of blood with the metabolic demand of various tissues under wide-ranging conditions. One primary regulator of vasomotion and thus perfusion to...

Trial Type

Interventional

Trial Phase

Phase 1

Sponsorship

Russell Richardson

Clinicaltrials.gov

Pulmonary Rehab in COPD: Response to Tyvaso

The investigators' hypothesis is that pretreating patients with COPD with inhaled treprostinil prior to pulmonary rehabilitation sessions will result in improved exercise tolerance during sessions. This in...

Trial Type

Interventional

Trial Phase

Phase 2

Sponsorship

Inova Health Care Services

Clinicaltrials.gov

Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study

Chronic obstructive pulmonary disease (COPD) is often caused by cigarette smoking, but genetic predisposition also influences COPD susceptibility. The purpose of this study is to identify genetic factors that...

Trial Type

Observational

Sponsorship

National Heart, Lung, and Blood Institute (NHLBI)

Treatments Today

Many current treatments for chronic obstructive pulmonary disease (COPD) alleviate symptoms through bronchodilators, which relax the muscles around the airways.

Prescription treatments on the market in 2019.

Azithromycin

Azithromycin prevents exacerbations of COPD (acute bronchitis, pneumonia and influenza), but it isn't clear whether this is due to its antibiotic effect or its anti-inflammatory properties.

Availablity

Brands

Azasite, Azithromycin 3 Day Dose Pack, Azithromycin 5 Day Dose Pack, Zithromax, Zithromax TRI-PAK, Zithromax Z-Pak, Zmax

Drug Class

Macrolide Antibiotics

Generic

Azithromycin

mayoclinic.org

Albuterol

Albuterol is a bronchodilator used to prevent and treat wheezing, difficulty breathing, chest tightness, and coughing caused by lung diseases such as asthma and chronic obstructive pulmonary disease (COPD). Albuterol relaxes and opens the air passages to the lungs to make breathing easier. Albuterol belongs to class of drugs called short-acting beta-2- agonist bronchodilators. Available in different formulations, including oral syrups, inhalation powders, inhalation suspensions, and inhalation solutions.

Availablity

Brands

ProAir HFA, ProAir RespiClick, Proventil HFA, Ventolin HFA, AccuNeb

Drug Class

Short-acting Beta2-agonists (Bronchodilators)

Generic

Albuterol

medlineplus.gov

Inhaled combination of Indacaterol and Glycopyrrolate

Utibron Neohaler, a combination medicine containing glycopyrrolate and indacaterol, is used to prevent airflow obstruction or bronchospasm in people with COPD. Glycopyrrolate is an anticholinergic. Indacaterol is a bronchodilator. These medications work by relaxing muscles in the airways to improve breathing. Utibron Neohaler should not be used in patients with asthma. Indacaterol may increase the risk of death in people with asthma, but the risk in people with COPD is not known.

Availablity

Brands

Utibron Neohaler

Drug Class

Combination Inhaled Medicine: Beta2 Agonist + Anticholinergic

Generic

Glycopyrrolate and Indacaterol (Inhalation)

drugs.com

Inhaled Indacaterol

Inhaled indacaterol is a bronchodilator used to control wheezing, shortness of breath, coughing, and chest tightness caused by COPD. It works by relaxing and opening air passages in the lungs, making it easier to breathe. Indacaterol belongs to class of drugs called long-acting beta-2- agonists. It's available in a 75 mcg capsule.

Availablity

Brands

Arcapta Neohaler

Drug Class

Long-acting Beta2-agonists (Bronchodilators)

Generic

Indacaterol

medlineplus.gov

Inhaled Ipratropium Bromide

Inhaled ipratropium is a bronchodilator used to prevent wheezing, shortness of breath, coughing, and chest tightness in COPD patients. It works by relaxing and opening air passages in the lungs, making it easier to breathe. Ipratropium belongs to a class of medications called short-acting anticholinergics.

Availablity

Brands

Atrovent, Atrovent HFA

Drug Class

Short-acting Anticholinergics (Bronchodilators)

Generic

Ipratropium inhalation

mayoclinic.org

Roflumilast

Roflumilast is used in people with severe COPD to reduce the number of episodes or worsening of COPD symptoms. The drug works by decreasing inflammation (swelling) in the lungs. Roflumilast belongs to a class of drugs called phosphodiesterase inhibitors..

Availablity

Brands

Daliresp

Drug Class

Phosphodiesterase-4 Inhibitors

Generic

Roflumilast

mayoclinic.org

Theophylline

Theophylline is used to prevent and treat wheezing, shortness of breath, and chest tightness caused by asthma, chronic bronchitis, emphysema, and other lung diseases. It relaxes and opens air passages in the lungs, making it easier to breathe.

Availablity

Brands

Aerolate III, JR, and SR, Bronkodyl, Elixophyllin, Quibron-T/SR, Respbid, Slo-Bid Gyrocaps, Slo-Phyllin, T-Phyl, Theo-24, Theo-Dur, Theo-Time, Theo-X, Theobid, Theochron, Theoclear LA-130, Theoclear LA-260, Theolair, Theolair-SR, Theovent, Uni-Dur, Uniphyl

Drug Class

Methylxanthines

Generic

Theophylline

medlineplus.gov

Tiotropium

Tiotropium is a bronchodilator used to prevent wheezing, shortness of breath, coughing, and chest tightness in COPD patients. It works by relaxing and opening air passages in the lungs, making it easier to breathe. Tiatropium belongs to a class of medications called long-acting anticholinergics.

Availablity

Brands

Spiriva, Spiriva Respimat, Spiriva HandiHaler, Spiriva Respimat 30 Dose, Spiriva Respimat 14 Dose, Spiriva Respimat 28 ACT, Spiriva Respimat 60 ACT

Drug Class

Long-acting Anticholinergics (Bronchodilators)

Generic

Tiotropium inhalation

mayoclinic.org

From the latest relevant research and COPD expert interviews to personal stories and advice on managing your symptoms, here’s everything about COPD that’s making headlines.

Pulmonology Advisor

Treatment Failure in COPD Reduced

Treatment failure may be significantly reduced by a 3-month course of azithromycin for acute chronic obstructive pulmonary disease (COPD) exacerbations that require hospitalization.

Learn More

Vancouver Sun

Inhaled steroids reduce risk of lung cancer in COPD patients: UBC study

Patients with chronic obstructive pulmonary disorder (COPD) who used inhaled steroids for their breathing problems had a 30 per cent reduced risk of getting lung cancer, according to a study by University of B.C. researchers.

Learn More

Medpage Today

Poor Sleep May Increase COPD Exacerbation Risk

Poor sleep quality, assessed using a validated sleep questionnaire, was associated with higher COPD exacerbation risk over 18 months of follow-up in a Canadian prospective cohort study.

Learn More

WebMD

Daily Aspirin Might Ease COPD Flare-Ups

MONDAY, March 4, 2019 (HealthDay News) -- Many Americans take a daily low-dose aspirin to protect their hearts. Now it appears aspirin may also reduce flare-ups of chronic obstructive pulmonary disease (COPD).

Learn More

WebMD

COPD May Strike Women Harder Than Men

WEDNESDAY, May 22, 2019 (HealthDay News) -- Women with chronic obstructive pulmonary disease (COPD) appear to have a harder time than men with the progressive lung disorder, a new study suggests.

Learn More

WebMD

Is Daily Vitamin D a Lifesaver for COPD Patients?

FRIDAY, Jan. 11, 2019 (HealthDay News) -- Deadly lung attacks may be averted in some COPD patients with a daily dose of vitamin D, new research suggests.

Learn More

Whether you’re considering participating in a clinical trial or just looking for more information about COPD, we want to keep you informed about living with COPD, your treatment options, and the clinical trial process.